STAAR Surgical(STAA) - 2024 Q2 - Quarterly Results

Exhibit 99.1 STAAR Surgical Reports Second Quarter 2024 Results Record Quarterly Net Sales of $99.0 Million;$100.4 Million in Constant Currency Raises Fiscal 2024 Net Sales and Adjusted EBITDA Outlook LAKE FOREST, CA, August 7, 2024 --- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial results for the second quarter ended June 28, 2024. Second Qua ...